单词aromatase inhibitor
网络: 芳香酶抑制剂；芳香脢抑制剂；芳香化酶抑制剂
Estrogen receptor modulators, aromatase inhibitor, ovarian ablation are the primary means of endocrine treatment of breast cancer.
雌激素受体调节剂、芳香化酶抑制剂、卵巢去势等是乳腺癌内分泌治疗的主要手段。
Women in the placebo group, not on an aromatase inhibitor, maintained BMD at the spine, but had a significant 1. 2% loss at the total hip.
未服用芳香化酶抑制剂的妇女脊柱骨密度保持不变，全髋关节下降1.
In addition, there was no increased risk of death from other causes in women who were prescribed the aromatase inhibitor.
另外服用芳香酶抑制剂的妇女的其他原因的死亡率没有增加。
In women on an aromatase inhibitor and risedronate, spine BMD fell by 2. 4% and remained stable at the hip.
利塞膦酸组中，服用芳香化酶抑制剂的妇女脊柱骨密度下降2.4%，全髋关节密度保持不变。
At baseline, 13% of the women were taking an aromatase inhibitor. This rose to 44% by the end of the 24-month study.
基线水平上，13%的妇女正服用芳香化酶抑制剂。两年后，这一比例升高到了44%。
Clinical analysis of relapsed endometrial carcinoma treated with aromatase inhibitor lantaron
芳香化酶抑制剂治疗晚期复发性子宫内膜癌初探
Development of an aromatase inhibitor screening assay
芳香化酶抑制剂筛选模型的建立